SMTL ID : 8bw0.1

Structure of CEACAM5 A3-B3 domain in Complex with Tusamitamab Fab

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain C: N.10, D.19 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 5 residues within 4Å: Chain C: P.149, N.150, T.175, S.177, A.178 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:S.177

1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-FUC.2: 7 residues within 4Å: Chain A: S.30, G.54, G.55, G.56 Chain C: S.101, N.114, F.143 No protein-ligand interaction detected (PLIP)

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 1 residues within 4Å: Chain C: N.55 No protein-ligand interaction detected (PLIP) NAG.5: 3 residues within 4Å: Chain C: F.158, S.160, N.167 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:F.158 Hydrogen bonds: C:S.160, C:N.167 NAG.6: 2 residues within 4Å: Chain C: D.17, N.62 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rak, A. et al., Structural insights into epitope-paratope interactions of monoclonal antibody targeting CEACAM5-expressing tumors. Res Sq (2023)

Release Date

2024-01-24

Peptides

Tusamitamab Fab heavy Chain: A
Tusamitamab Light Chain: B
Carcinoembryonic antigen-related cell adhesion molecule 5: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
C

Tusamitamab Fab heavy Chain

Tusamitamab Light Chain

Carcinoembryonic antigen-related cell adhesion molecule 5